Dr Murdoch is a highly experienced global pharmaceutical, biotechnology and healthcare executive with more than 30 years’ experience across listed and private companies in Australia, the United States and Europe.
He brings direct experience in neurology and neurodegenerative disease programs, combined with a strong track
record in commercial strategy, operational execution and value realisation across the product lifecycle.
Dr Murdoch has held senior leadership roles with AstraZeneca, GlaxoSmithKline and Shire Pharmaceuticals,
spanning clinical development, global project leadership, commercial execution and strategic growth initiatives.
He also brings deep United States market experience, having lived and worked extensively in the US across both
multinational pharmaceutical and emerging biotechnology companies. His experience includes US clinical
development environments, capital markets engagement, strategic transactions and scaling businesses
internationally. Dr Murdoch holds dual Australian and United States citizenship.
Dr Murdoch has significant ASX–listed company governance experience, having previously served as Chief Executive Officer and Managing Director of Avecho Biotechnology Limited and continuing as a Non–Executive Director. He is currently Chief Executive Officer and President of Extractas Bioscience, where he has led a significant operational transformation and growth program.
He brings direct experience in neurology and neurodegenerative disease programs, combined with a strong track
record in commercial strategy, operational execution and value realisation across the product lifecycle.
Dr Murdoch has held senior leadership roles with AstraZeneca, GlaxoSmithKline and Shire Pharmaceuticals,
spanning clinical development, global project leadership, commercial execution and strategic growth initiatives.
He also brings deep United States market experience, having lived and worked extensively in the US across both
multinational pharmaceutical and emerging biotechnology companies. His experience includes US clinical
development environments, capital markets engagement, strategic transactions and scaling businesses
internationally. Dr Murdoch holds dual Australian and United States citizenship.
Dr Murdoch has significant ASX–listed company governance experience, having previously served as Chief Executive Officer and Managing Director of Avecho Biotechnology Limited and continuing as a Non–Executive Director. He is currently Chief Executive Officer and President of Extractas Bioscience, where he has led a significant operational transformation and growth program.
